These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Topical retinoic acid inhibits changes in Langerhans cell density during carcinogenesis. Halliday GM; McKay DA In Vivo; 1993; 7(3):271-6. PubMed ID: 8357969 [TBL] [Abstract][Full Text] [Related]
24. Epidermal Langerhans' cells and their function in the skin immune system. Hogan AD; Burks AW Ann Allergy Asthma Immunol; 1995 Jul; 75(1):5-10; quiz 10-2. PubMed ID: 7621061 [TBL] [Abstract][Full Text] [Related]
27. Phagocytosis of antigens by Langerhans cells. Reis e Sousa C; Austyn JM Adv Exp Med Biol; 1993; 329():199-204. PubMed ID: 8379370 [No Abstract] [Full Text] [Related]
28. Depletion of Langerhans cells following carcinogen treatment is partly due to antigenicity. Woods GM; Liew IH; Muller HK Adv Exp Med Biol; 1993; 329():623-7. PubMed ID: 8379436 [No Abstract] [Full Text] [Related]
29. Antigen presentation in the skin: modulation by u.v. radiation and chemical carcinogens. Muller HK; Bucana C; Kripke ML Semin Immunol; 1992 Aug; 4(4):205-15. PubMed ID: 1391795 [TBL] [Abstract][Full Text] [Related]
30. Studies on Langerhans cell phenotype in human afferent skin lymph from allergic contact dermatitis. Brand CU; Hunziker T; Gerber HA; Schaffner T; Limat A; Braathen LR Adv Exp Med Biol; 1995; 378():523-5. PubMed ID: 8526132 [No Abstract] [Full Text] [Related]